Interestingly, examining expression (Fig 4b) revealed that in the same luminal A breast cancers INHA, ENG and INHBA are less expressed in responders to pharmacological treatment while TGFBR3 is more expressed in these responder groups (Fig 4b). This evidence concerns the gene INHBA and breast carcinoma.